New York-based AI clinical care platform Nabla has raised $70 million in capital to accelerate product development and support national growth. The funding round was led by HV Capital, with participation form Highland Europe, DST Global and existing investors Cathay Innovation and Tony Fadell’s Build Collective.
According to a news release, Nabla’s AI assistant is currently used in over 130 healthcare organizations, including CVS Health, Children’s Hospital Los Angeles and Carle Health. Originally focused on clinical documentation, the assistant is now evolving into an agentic AI model, capable of enhancing clinical documentation integrity and adapting across various clinical settings and roles.
“We’re going even deeper into clinical workflows while continuing to offer a highly customizable assistant that works across specialties. Clinicians already trust our accuracy and speed, and this funding allows us to expand that impact by embedding intelligent support directly into care delivery. We see a future where AI not only documents care, but actively drives efficiency by executing actions within complex clinical workflows and environments,” Alex Lebrun, CEO of Nabla, said in a statement.
